NBCA glue mixing is where interventional radiology becomes chemistry in real time. N-butyl-2-cyanoacrylate is a liquid monomer that polymerizes within seconds of touching blood — a property that makes it one of the most powerful tools in vascular embolization, and one of the least forgiving. The ratio you choose, the syringe you mix in, and the moment you stop injecting all determine whether the cast forms safely in the nidus or catastrophically in the catheter.

Few embolic agents demand this level of preparation. A coil overshoots and you retrieve it; a particle passes and you wait; glue misbehaves and the window to act is measured in heartbeats. Reviews of embolization practice consistently show that most glue complications — catheter entrapment, non-target embolization, reflux — are procedural, not pharmacological^19,22. In other words, they are teachable and preventable.

This module — the foundation of the SATMix Vascular learning track — teaches NBCA glue mixing the way I teach it to fellows: from the reaction kinetics upward, so that every decision at the table follows from first principles. Seven rules, one protocol, zero improvisation.

1. NBCA chemistry 101

Understanding the molecule takes three minutes and prevents three years of complications. NBCA is an alkyl-2-cyanoacrylate monomer. In the bottle it is stable; the moment it encounters anions — hydroxyl ions in blood, water on tissue, even the ionic contrast in a poorly flushed line — it begins anionic polymerization. The monomers link into long chains, the liquid gels, and within seconds the gel solidifies into a hard cast. Kinetic studies of Glubran 2 and Histoacryl mixed with iodized oil confirm that the mixture is a true solution, and that polymerization rate falls predictably as oil content rises².

Two properties deserve respect. First, speed: undiluted NBCA can polymerize almost instantly at body temperature, leaving no working time. Second, exothermia: polymerization releases heat, and concentrated glue can generate enough thermal energy to injure adjacent tissue. Dilution with Lipiodol moderates both — slowing the reaction and lowering peak temperature — which is why the ratio is not a convenience but the central safety variable^1,2.

Formulations you will meet

• Histoacryl (n-butyl-2-cyanoacrylate): the reference formulation; fast, widely used, mixed with Lipiodol for radiopacity.
• Glubran 2: a modified cyanoacrylate with slightly slower polymerization and lower exothermic profile.
• Tantalum-loaded or other opacified variants: regional preferences exist; know your product's kinetics before the case.

Where polymerization actually begins

Trainees picture the glue setting inside the vessel; in practice, the reaction starts the instant the mixture touches anything ionic — the first millilitre of blood at the catheter tip, a droplet of contrast left in a three-way tap, even the moisture on gloved hands. This is why the non-ionic flush is not ritual: it resets the catheter lumen to a trigger-free state immediately before NBCA glue mixing enters the delivery line. Kinetic measurements in blood-mimicking conditions show mixtures remaining workable for tens of seconds to several minutes depending on oil content — a window that shrinks dramatically if ionic contamination shortens it².

Exothermia deserves equal respect. Polymerization of concentrated cyanoacrylate is measurably exothermic, and while clinical injury is uncommon with diluted mixtures, concentrated glue deposited against neural structures or thin mucosa has produced thermal and inflammatory complications in the literature. The working rule I teach is simple: the more concentrated the mixture and the more delicate the bed, the more justification you need for the ratio you chose⁴.

2. The Lipiodol ratio table

Lipiodol is the accelerator pedal in reverse. Mixed with NBCA, ethiodized oil does two jobs: it makes the glue visible under fluoroscopy, and it acts as a polymerization retardant, stretching working time and pushing the solidification front further down the vascular tree. Across the published spectrum — from glue-dominant 0.5:1 to oil-dominant 3:1 Lipiodol-to-glue — clinical teams tune three linked variables: time to set, penetration depth, and cast strength^1,10.

Reading the ratio table

• High-flow lesions (AVMs, bleeding arteries): richer glue loads polymerize fast enough to anchor before migration — accepting a more proximal cast.
• Distal, delicate beds (small pseudoaneurysms, distal branches): higher oil content buys time for controlled, distal deposition.
• Long injection paths: remember transit time — the glue starts polymerizing the moment it enters blood, not when it exits the catheter.

Institutions differ on notation, so standardize your vocabulary. Some teams write glue-to-oil, others oil-to-glue; trauma series report NBCA:Lipiodol from 1:2 to 1:5, while gastroenterology bleeding literature describes 1:3 as a workhorse mixture^9,10,13. Whatever convention your NBCA glue mixing protocol chooses, write the ratio, the product, and the target time in the case record — ambiguity here has caused more near-misses than any catheter.

Worked examples: three lesions, three ratios

• Brisk gastric ulcer bleed: a flow that would carry a coil downstream calls for a glue-rich mixture that anchors on contact; teams classically land near a 1:3 glue-to-oil working blend with brisk, monitored injection⁹.
• Small renal pseudoaneurysm: the target is a few millimetres wide beyond a parent artery you must preserve; an oil-rich blend buys the seconds needed for controlled distal deposition¹².
• High-flow AVM nidus: staged sessions with flow-adapted mixtures, sometimes with balloon occlusion, balancing penetration against migration risk²³.

The unifying principle: choose the slowest mixture that still achieves occlusion. Extra working time is the cheapest safety margin in NBCA glue mixing.

3. Mixing under pressure

NBCA glue mixing happens in one of the harshest micro-environments in the cath lab: a viscous, oil-based adhesive handled under time pressure. Standard polycarbonate syringes were never designed for this. The Lipiodol component initiates the same stress-cracking seen in chemoembolization work — hazing within minutes, crazing shortly after, structural failure within the hour — while the glue itself attacks plungers and hubs. Applying manual injection force to a compromised barrel is how syringes burst in a technologist's hands.

The practical requirements for NBCA glue mixing hardware are therefore threefold: oil-resistant barrels that survive the whole case, Luer interfaces that seat and seal without weeping adhesive, and a circuit that never opens. The SATMix vascular set meets these with Lipiodol-resistant, A-grade polymers and a closed-loop configuration — the same materials science platform validated in the oncology track, now specified for glue viscosity and working pressure.

Viscosity is the operational variable nobody budgets for. Oil-glue mixtures prepared during NBCA glue mixing are an order of magnitude thicker than saline or contrast, so every internal diameter in the NBCA glue mixing circuit — syringe barrel, stopcock bore, catheter lumen — multiplies the force required at the plunger. Teams feel this as "sticky" plungers and jerky injection starts, and jerky starts are precisely what produce reflux surges. Smooth NBCA glue mixing demands smooth hardware: polished bores, generous stopcock channels, and components rated for the pressure a viscous mixture needs¹.

4. Choosing your embolic agent

Glue is magnificent — when the lesion is right. The modern embolic armamentarium spans temporary mechanical agents (gelatin sponge), permanent particles and microspheres, coils and plugs, and two families of liquid embolics: cyanoacrylates (NBCA) and DMSO-based copolymers (Onyx, PHIL, Squid). Comparative reviews show each occupies a distinct niche defined by flow, target diameter, catheter dwell time, and the operator's need for control^4,5.

Glue wins when speed matters and dwell time must be short: high-flow shunts, brisk bleeding where coils would migrate, tortuous anatomy where a catheter cannot sit still, and cost-sensitive settings where DMSO agents are impractical. The DMSO family wins when long, controlled injections through a wedged catheter are planned. Neither is universal; the decision flowchart below is the conversation I have with every fellow before the tray is opened.

Adjuncts worth mastering

Gelatin sponge (Gelfoam) slurry remains the workhorse temporary adjunct — for trauma damage control, pre-operative portal vein embolization support, and post-partum hemorrhage — degrading over days to weeks while definitive occlusion matures. In liver-directed work, NBCA has become a primary agent for portal vein embolization, with meta-analytic data supporting robust future-liver-remnant hypertrophy^17,23.

5. Safety architecture: the closed loop

Every open Luer in a glue setup is three hazards at once: a portal for air, a spill point for adhesive, and a polymerization trigger if blood tracks back into the line. NBCA glue mixing through a closed loop eliminates all three by design. The mixing syringes, stopcock, and delivery line form one continuous fluid pathway from preparation to injection; nothing separates, nothing is exposed, and the circuit can be flushed with non-ionic solution between phases without breaking sterility.

The closed loop also standardizes the critical pre-flush: clearing ionic residue from the delivery limb before glue enters the circuit. Because the pathway is fixed and labelled, the flush sequence becomes protocol rather than memory — which is precisely how you want safety-critical steps engineered. Air embolism during embolization procedures, though under-reported, carries neurological and cardiovascular consequences that no outcome statistic can excuse²¹.

6. Complications and prevention

Large-cohort data show glue embolization is safe in experienced hands — but the complication taxonomy is specific, and each failure mode maps to a specific preventive habit^3,19.

Catheter entrapment

The signature glue complication: polymerization begins in or around the catheter tip, and withdrawal welds the device into the vessel. Prevention is ratio discipline, slow injection, and the hard rule that the catheter is a single-use consumable — you withdraw it before the glue sets, every time, and you accept losing it. Published rescue maneuvers, including snaring of glued microcatheters, exist precisely because this still happens⁶.

Reflux and non-target embolization

Injecting faster than inflow allows the glue to wash backward into parent vessels — occluding normal territory. The stop rule is absolute: at the first hint of reflux, stop. If reflux is anticipated, balloon-occluded delivery or a plug-and-push strategy converts an uncontrolled reflux situation into a controlled deposition^1,23. Non-target embolization in high-flow shunts can reach the lungs; screening for shunts and staging embolization across sessions is the standard of care in AVM work^7,23.

Thermal and inflammatory injury

Exothermic polymerization, especially with concentrated mixtures adjacent to neural structures or delicate mucosa, can cause pain and tissue injury; inflammatory foreign-body reactions are described with all liquid embolics. Adequate Lipiodol dilution near sensitive beds, and staged rather than heroic sessions, reduce both^2,4.

Migration and shunt screening

In high-flow lesions, the glue's destination is decided by physics, not intention: if inflow carries the liquid past the nidus before it sets, the lungs become the unintended embolization bed. Systematic reviews of cerebral and peripheral AVM practice consistently recommend angiographic shunt assessment before embolization, staged sessions for large shunts, and mixture adaptation as flow falls between sessions^7,23. A short prophylactic dialogue with anesthesia before high-flow cases — "if saturations fall, tell me immediately" — closes the loop between the angio suite and the monitor.

7. The NBCA mixing protocol

This protocol condenses Module 2.2 of the SATMix Vascular track. It assumes the SATMix vascular set, a non-ionic flush discipline, and a team that has verbalized the ratio, the set time, and the stop rule before the first drop of glue moves.

Step 1 — Prepare the field

1. Lay out the SATMix vascular set in connection order; confirm NBCA and Lipiodol volumes for the target ratio.
2. Stage non-ionic flush solution; confirm no ionic contrast or blood contaminates any limb of the circuit.
3. Assign the verbal roles: who calls the ratio, who watches the roadmap, who watches the clock.

Step 2 — Pre-flush the catheter

Flush the microcatheter with non-ionic solution until return is crystal clear. Blood or ionic residue in the catheter is a polymerization trigger waiting at the tip. This step, boring as it is, prevents the majority of entrapment events^1,6.

Step 3 — Mix in the closed loop

Draw the components into the loop and exchange between the Lipiodol-resistant syringes until the mixture is homogeneous — uniform opacity, no streaking. NBCA glue mixing in a closed loop takes seconds, protects the operator from adhesive contact, and keeps the mixture isolated from triggers until the moment of injection.

Step 4 — Inject with a stop rule

Inject slowly under continuous roadmap fluoroscopy, watching for the cast to approach dangerous junctions. Agree the stop rule aloud before starting: "reflux means stop." If a plug-and-push or balloon-occluded technique is planned, establish it before the glue is in the catheter²³.

Step 5 — Withdraw and discard

Withdraw the catheter smoothly before the glue sets, as a single unit, and discard it. Never test whether the catheter is "still free" by tugging. Document ratio, volumes, set time observed, injection duration, and any reflux — your registry entry is the next operator's textbook.

8. Clinical scenarios and follow-up

The technique travels well. In acute non-variceal gastrointestinal bleeding, NBCA transarterial embolization achieves hemostasis in over 90% of cases across systematic reviews — often after failed endoscopic therapy^8,9,28. In polytrauma, it controls abdominopelvic hemorrhage when coagulopathy makes surgery perilous, with European trauma guidelines endorsing early angioembolization in the bleeding protocol^10,18. Visceral artery pseudoaneurysms — pancreatic, hepatic, splenic — are occluded with modified injection techniques that keep glue out of the parent artery^11,12,14. Renal angiomyolipomas, prostatic artery embolization, and lymphatic leakage complete the periphery of the map^15,16,24.

In liver surgery planning, NBCA has become a first-line agent for portal vein embolization, inducing hypertrophy of the future liver remnant with a favorable profile compared with particle-based embolization in meta-analytic comparisons; newer liver vein deprivation techniques extend the same physics with combined embolic approaches¹⁷.

Explaining the procedure to patients

Patients hear "medical superglue" and picture a craft project. The better analogy is caulking a crack: we guide a liquid that hardens in seconds to precisely the spot that bleeds or tangles, using X-ray vision the whole way. Every team member should be able to deliver this one-minute explanation — confident patient communication is part of safe NBCA glue mixing practice, because a calm, informed patient lies still, and a still patient is a safer field.

Follow-up is lesion-specific: confirm hemostasis and re-bleeding surveillance in hemorrhage work, staged angiographic reassessment in AVMs, and cross-sectional imaging after pseudoaneurysm or tumor embolization. Whatever the indication, document and debrief with a standardized complication taxonomy — departments that classify learn faster than departments that remember^20,22.

Conclusion

NBCA glue mixing rewards the same virtues everywhere it is practiced: respect for the chemistry, discipline with the ratio, hardware that survives the mixture, and a circuit that never opens. None of this is exotic; all of it is learnable, and all of it prevents the complications that statistics attribute to "glue" but that experience attributes to preparation.

Every ratio verbalized, every circuit closed, and every catheter withdrawn on time compounds into the same result: predictable casts, intact devices, and calm teams. Standardize the technique, and the agent becomes what it was designed to be — the fastest, most definitive tool in the embolization armamentarium. The SATMix Vascular track exists to make that standardization the path of least resistance.